Evidence map›Paper›PMID 27154966›Full record

ArticleJournal of the National Cancer Institute2016

RE: HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer.

Luis G Carvajal-Carmona, Ian Tomlinson, Ruta Sahasrabudhe

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the National Cancer Institute, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Luis G Carvajal-CarmonaGenome Center and Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, Davis, CA (LGCC, RS); Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (IT) lgcarvajal@ucdavis.edu.
Ian TomlinsonGenome Center and Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, Davis, CA (LGCC, RS); Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (IT).
Ruta SahasrabudheGenome Center and Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, Davis, CA (LGCC, RS); Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (IT).

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Gina M Dayton · 2002 to 2026
$84.9M
UC Davis Paul Calabresi K12 Clinical Oncology Research Career Development ProgramK12CA138464 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BIRKELAND, ANDREW CHARLES, LARA, PRIMO N. · 2011 to 2025
$11.4M
NCI NIH HHS K12 CA138464NCI NIH HHS P30 CA093373
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, PapillaryHumansMutationSerine EndopeptidasesThyroid Cancer, PapillaryThyroid NeoplasmsHABP2 protein, humanSerine Endopeptidases

Identifiers

PMID27154966
PMCPMC5017950

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.